Use of NovoSeven® in Active Variceal Bleeding

PHASE2CompletedINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Acquired Bleeding DisorderCirrhosis
Interventions
DRUG

activated recombinant human factor VII

Trial Locations (44)

32

Novo Nordisk Investigational Site, Shatin

112

Novo Nordisk Investigational Site, Taipei

8000

Novo Nordisk Investigational Site, Aarhus

12821

Novo Nordisk Investigational Site, Prague

13353

Novo Nordisk Investigational Site, Berlin

13385

Novo Nordisk Investigational Site, Marseille

14004

Novo Nordisk Investigational Site, Córdoba

14033

Novo Nordisk Investigational Site, Caen

20162

Novo Nordisk Investigational Site, Milan

28007

Novo Nordisk Investigational Site, Madrid

28034

Novo Nordisk Investigational Site, Madrid

28222

Novo Nordisk Investigational Site, Majadahonda

30146

Novo Nordisk Investigational Site, Palermo

31059

Novo Nordisk Investigational Site, Toulouse

38043

Novo Nordisk Investigational Site, Grenoble

44093

Novo Nordisk Investigational Site, Nantes

48145

Novo Nordisk Investigational Site, Münster

49033

Novo Nordisk Investigational Site, Angers

59037

Novo Nordisk Investigational Site, Lille

69120

Novo Nordisk Investigational Site, Heidelberg

75012

Novo Nordisk Investigational Site, Paris

75013

Novo Nordisk Investigational Site, Paris

77520

Novo Nordisk Investigational Site, Olomouc

80131

Novo Nordisk Investigational Site, Napoli

81377

Novo Nordisk Investigational Site, München

87042

Novo Nordisk Investigational Site, Limoges

89081

Novo Nordisk Investigational Site, Ulm

94804

Novo Nordisk Investigational Site, Villejuif

A 1090

Novo Nordisk Investigational Site, Vienna

140 21

Novo Nordisk Investigational Site, Prague

00029 HUS

Novo Nordisk Investigational Site, Helsinki

92 188

Novo Nordisk Investigational Site, Clichy

06202

Novo Nordisk Investigational Site, Nice

04103

Novo Nordisk Investigational Site, Leipzig

40-752

Novo Nordisk Investigational Site, Katowice

31-826

Novo Nordisk Investigational Site, Krakow

02-097

Novo Nordisk Investigational Site, Warsaw

08916

Novo Nordisk Investigational Site, Badalona

08003

Novo Nordisk Investigational Site, Barcelona

08025

Novo Nordisk Investigational Site, Barcelona

08036

Novo Nordisk Investigational Site, Barcelona

LS9 7TF

Novo Nordisk Investigational Site, Leeds

WC1 6HX

Novo Nordisk Investigational Site, London

OX3 9DU

Novo Nordisk Investigational Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00154492 - Use of NovoSeven® in Active Variceal Bleeding | Biotech Hunter | Biotech Hunter